This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock SRNG vs. RVMD, ADMA, KRYS, PCVX, ACLX, CRSP, SRRK, SWTX, IMVT, and ALVOShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Revolution Medicines (RVMD), ADMA Biologics (ADMA), Krystal Biotech (KRYS), Vaxcyte (PCVX), Arcellx (ACLX), CRISPR Therapeutics (CRSP), Scholar Rock (SRRK), SpringWorks Therapeutics (SWTX), Immunovant (IMVT), and Alvotech (ALVO). Soaring Eagle Acquisition vs. Revolution Medicines ADMA Biologics Krystal Biotech Vaxcyte Arcellx CRISPR Therapeutics Scholar Rock SpringWorks Therapeutics Immunovant Alvotech Revolution Medicines (NASDAQ:RVMD) and Soaring Eagle Acquisition (NASDAQ:SRNG) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation. Do institutionals & insiders have more ownership in RVMD or SRNG? 94.3% of Revolution Medicines shares are owned by institutional investors. Comparatively, 41.2% of Soaring Eagle Acquisition shares are owned by institutional investors. 8.0% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media favor RVMD or SRNG? In the previous week, Revolution Medicines had 8 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 8 mentions for Revolution Medicines and 0 mentions for Soaring Eagle Acquisition. Revolution Medicines' average media sentiment score of 1.71 beat Soaring Eagle Acquisition's score of 0.20 indicating that Revolution Medicines is being referred to more favorably in the media. Company Overall Sentiment Revolution Medicines Very Positive Soaring Eagle Acquisition Neutral Do analysts recommend RVMD or SRNG? Revolution Medicines currently has a consensus price target of $66.67, indicating a potential upside of 72.80%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts clearly believe Revolution Medicines is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation & earnings, RVMD or SRNG? Soaring Eagle Acquisition has lower revenue, but higher earnings than Revolution Medicines. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$742K9,666.47-$436.37M-$3.57-10.81Soaring Eagle AcquisitionN/AN/AN/AN/AN/A Is RVMD or SRNG more profitable? Soaring Eagle Acquisition's return on equity of 0.00% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -33.67% -30.08% Soaring Eagle Acquisition N/A N/A N/A Does the MarketBeat Community believe in RVMD or SRNG? Revolution Medicines received 97 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformRevolution MedicinesOutperform Votes9776.98% Underperform Votes2923.02% Soaring Eagle AcquisitionN/AN/A SummaryRevolution Medicines beats Soaring Eagle Acquisition on 9 of the 11 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$1.70B$2.93B$7.08B$7.70BDividend YieldN/A1.91%10.99%4.33%P/E RatioN/A30.4347.9518.31Price / SalesN/A478.5222,904.58107.09Price / CashN/A168.6835.4434.62Price / BookN/A3.783.454.25Net IncomeN/A-$72.06M$4.29B$247.51M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$7.87+3.6%N/A+773.1%$1.70BN/A0.00N/ARVMDRevolution Medicines3.892 of 5 stars$36.76+1.5%$66.67+81.4%+8.4%$6.83B$742,000.00-10.24250Positive NewsADMAADMA Biologics1.9108 of 5 stars$21.31+0.4%$22.50+5.6%+245.7%$5.04B$426.45M76.11530Positive NewsKRYSKrystal Biotech4.7559 of 5 stars$168.57+2.3%$220.00+30.5%+6.3%$4.87B$290.52M56.38210News CoveragePositive NewsPCVXVaxcyte3.1733 of 5 stars$30.65+5.3%$136.50+345.4%-42.8%$3.95BN/A-6.66160Analyst ForecastAnalyst RevisionPositive NewsACLXArcellx1.9066 of 5 stars$62.02+2.2%$110.67+78.4%+21.1%$3.41B$107.94M-87.3580News CoveragePositive NewsCRSPCRISPR Therapeutics2.9958 of 5 stars$37.770.0%$73.11+93.6%-29.7%$3.24B$35M-8.64473SRRKScholar Rock3.5742 of 5 stars$30.71+3.2%$42.67+39.0%+144.0%$2.91B$33.19M-13.07140News CoveragePositive NewsSWTXSpringWorks Therapeutics2.2042 of 5 stars$37.89+0.4%$73.20+93.2%+3.6%$2.84B$191.59M-10.89230Upcoming EarningsNews CoverageIMVTImmunovant1.9795 of 5 stars$15.15+2.1%$41.00+170.6%-47.7%$2.57BN/A-5.78120Analyst ForecastPositive NewsALVOAlvotech2.0772 of 5 stars$8.29-0.4%$18.00+117.1%-38.2%$2.50B$489.68M-4.484 Related Companies and Tools Related Companies RVMD Alternatives ADMA Alternatives KRYS Alternatives PCVX Alternatives ACLX Alternatives CRSP Alternatives SRRK Alternatives SWTX Alternatives IMVT Alternatives ALVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNG) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
